JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancerSarah Alexandrou, C. Elizabeth Caldon|Journal of Experimental & Clinical Cancer Research|2025Cited by 1